Designing pregnancy centered medications: drugs which do not cross the human placenta.
about
Influenza and its treatment during pregnancy: A review.Breast cancer in pregnancy: a literature review.Antibiotic Treatment of Dogs and Cats during Pregnancy.ATP-binding cassette efflux transporters in human placenta.Clinical therapeutics in pregnancy.Drug transport across the placenta, role of the ABC drug efflux transporters.Comparison of Glibenclamide and Insulin on Neonatal Outcomes in Pregnant Women with Gestational DiabetesMaternal administration of anti-angiogenic agents, TNP-470 and Angiostatin4.5, induces fetal microphthalmia.Chemotherapy against cancer during pregnancy: A systematic review on neonatal outcomes.Drug transporters in the human blood-placental barrier.Oral hypoglycemic agents for gestational diabetes mellitus?Current toxicological aspects on drug and chemical transport and metabolism across the human placental barrier.Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure.Effects of fetal exposure to maternal chemotherapy.Use of anticancer agents in gynecological oncology during pregnancy: a systematic review of maternal pharmacokinetics and transplacental transfer.Pharmacokinetic studies in pregnant women.Pharmacokinetic profiling of efavirenz-emtricitabine-tenofovir fixed dose combination in pregnant and non-pregnant rats.Investigating the potential role of multi-drug resistance protein (MRP) transporters in fetal to maternal glyburide efflux in the human placenta.The role of the placenta in drug transport and fetal drug exposure.Addressing concerns about cisplatin application during pregnancy.Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs).Drug development for use during pregnancy: impact of the placentaDevelopment of Therapeutic Agents: The Maternal-Fetal Perspective
P2860
Q30384118-78995A67-B866-4E8D-98A7-479A6D30A2E4Q30423563-2AE3537E-64C4-40DC-AB72-8219EF52CAB7Q34495464-9C8B5D5A-6E3A-4A2F-B16F-26350BE56601Q34843023-54E17012-D200-40AA-82F5-5CFD28E64EA2Q35113890-9B11B42A-AB90-4F40-877C-E76C0D6376EAQ37008886-7E213842-3944-4252-8BF7-5CB593FA0F20Q37050976-FB0DA969-8236-4621-91E0-B63C3BDF48C9Q37246270-AD933356-CA58-479B-ADFD-044DCF0F181CQ37300632-DF2FA63D-6AA9-44AA-B7A7-CD2B4A927BDBQ37395889-0D3BE1D0-798B-407F-A06E-6642682BA3A9Q37826425-9916CBE0-28E2-4966-8400-0F097C477362Q38025182-63F03A53-3A62-4B99-A811-B3F85F462851Q38044958-AC2664E3-830A-4883-B4CC-B0E5C0670DC3Q38121738-F9246EC9-E3C8-44ED-AC23-892897E7330BQ38791566-F55B7F1C-C13D-4DC0-A54D-601C396CD88BQ42007783-EE5BA11C-76F7-4E0C-ACCF-E7242FC07C67Q43475720-94215E74-05FF-48EA-9853-714359CFFABEQ46319686-B5258A31-9226-40DD-8667-E80797804595Q47201255-24BFB2E0-6820-4732-84FC-02958FD8300AQ52897378-CEB93F87-55D5-45E3-9564-BD21E622AEC5Q53818047-3DE34D39-5F21-45E3-B0DC-612C60E68D28Q58392274-6046A0E1-85D4-48BF-B848-0902479771A4Q58862906-A87DBAE0-27FA-4601-9F6E-1FC1C568F751
P2860
Designing pregnancy centered medications: drugs which do not cross the human placenta.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Designing pregnancy centered medications: drugs which do not cross the human placenta.
@ast
Designing pregnancy centered medications: drugs which do not cross the human placenta.
@en
type
label
Designing pregnancy centered medications: drugs which do not cross the human placenta.
@ast
Designing pregnancy centered medications: drugs which do not cross the human placenta.
@en
prefLabel
Designing pregnancy centered medications: drugs which do not cross the human placenta.
@ast
Designing pregnancy centered medications: drugs which do not cross the human placenta.
@en
P1433
P1476
Designing pregnancy centered medications: drugs which do not cross the human placenta.
@en
P2093
P304
P356
10.1016/J.PLACENTA.2005.09.001
P577
2005-11-28T00:00:00Z